Establishing an Academic ARVC Program in Zurich
We have initiated an interdisciplinary clinical and scientific Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Program at the University Hospital Zurich in order to give greater consideration to this underestimated disease. This program’s clinical and research goals include the optimization of the interdisciplinary team-work for complex cases, state-of-the-art imaging, optimal therapy for progressive disease, ICD-therapy, catheter ablations, genetic testing and genetic counseling. We have started assembling a large clinical registry of ARVC patients in order to investigate clinical and genetic factors conferring an increased risk for disease manifestation, progression and a worse outcome. Furthermore, we have installed a multicenter ARVC biobank to study the molecular basis of ARVC and to define novel molecular mechanisms implicated in this complex disease.
Our multidisciplinary Zurich ARVC Program is kindly supported by the “Georg und Bertha Schwyzer-Winiker Stiftung” and the University of Zurich.